Back
Monte Rosa Therapeutics Vs. Evoke Pharma Industry Stock Comparison
Sell
34
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
Sell
17
EVOK
Evoke Pharma
Last Price:
4.56
Seasonality Move:
12.83%
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
- The current Monte Rosa Therapeutics [GLUE] share price is $8.48. The Score for GLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- GLUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy, Sell or Hold?
- The current Evoke Pharma [EVOK] share price is $4.37. The Score for EVOK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $8.48
The current trend is moderately bullish and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $4.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.
GLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 56.7 | Buy |
| Chaikin Money Flow: | -462366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
EVOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 35.88 | Sell |
| Chaikin Money Flow: | -25306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.9 - 6.06) | Sell |
| Bollinger Bands (100): | (4.53 - 6.19) | Sell |
GLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.23 | Sell |
| 20-day SMA: | 7.95 | Buy |
| 50-day SMA: | 6.51 | Buy |
| 200-day SMA: | 5.55 | Buy |
| 8-day EMA: | 8.91 | Sell |
| 20-day EMA: | 8.15 | Buy |
| 50-day EMA: | 6.93 | Buy |
| 200-day EMA: | 5.77 | Buy |
EVOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.25 | Sell |
| 20-day SMA: | 5.56 | Sell |
| 50-day SMA: | 5.07 | Sell |
| 200-day SMA: | 6.07 | Sell |
| 8-day EMA: | 5.06 | Sell |
| 20-day EMA: | 5.34 | Sell |
| 50-day EMA: | 5.29 | Sell |
| 200-day EMA: | 7.33 | Sell |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Evoke Pharma Earnings Growth & EVOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.
Monte Rosa Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Evoke Pharma Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||